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Background
• Many health systems have implemented some form of IV automation or 
compounding systems in their clean rooms.
• IV admixture automation is one of the most recent areas where technology 
has been added to pharmacy workflow. 
• Manufacturers tout that automated systems reduce the number of errors 
making it all the way to the patient.  
• Goals prior to automation implementation typically include: reducing 
pharmacy errors, improving accuracy, and improving productivity and 
workflow.  
• IV errors may lead to severe consequences up to and including death of the 
patient.  
• Currently, there is limited published literature or reports addressing the 
outcomes from this area of automation.
Types of IV Room Automation
RIVA® IV Room Automation Health Robotics IV Station®
Objectives
• Review key areas assessed by pharmacies prior to implementation 
and experiences realized following intravenous automation system 
implementation.
• Analyze whether health systems achieved goals of improved 
quality, safety, productivity, and a projected financial impact post 
implementation.
Methodology
• A questionnaire was developed and deployed anonymously using the 
Qualtrics® online survey platform.
• The questionnaire consisted of 45 questions in 4 key areas: quality; 
medication safety; productivity; and financial impact.
• The questionnaire was sent via direct email to approximately 200 targeted 
facilities across the United States.
• Respondents were also solicited using the ASHP Practice management 
discussion board and databases that contain pharmacy management 
information in mid to large size health-systems.
• Screening questions were used to eliminate participants that had no 
automation in their IV rooms.
• Approved by Marshall University IRB (IRBNet ID# 1045531-1).
Results
• 39 of 82 respondents (48%) met inclusion criteria.
• 20 of 34 respondents (59%) have had automation installed in the IV room for at least 3 
years.
• 6 of 27 respondents (22%) were able to provide feedback related to break-even costs 
or fiscal return
• 5 of 11 (45%) indicated no savings were realized related to IV room automation.
• 9 of 38 (24%) respondents indicated the systems helped automate dispensing of more 
than 300 IV products per day.
• 9 of 15 (60%) respondents indicated that no staffing changes were made, and 1 
reported a decrease in staffing as a result of the automation.
• 10 of 15 (67%) respondents indicated IV automation increased the time to perform IV 
admixture tasks.
Which IV automation product(s) did you 
implement?
Did the IV automation technology go through a formal 
ROI prior to purchase and implementation at your site?
Did the Pro Forma predict any decrease in medication 
























What was the predicted decrease in medication 
errors during routine preparation of IV medication 
following implementation of IV automation?
What was the change, if any, in the actual rate 
of medication errors following IV admixture 
automation?
Discussion and Implications
• Most respondents were unaware or their site did not use a formal ROI 
analysis or on-going assessment of fiscal impact associated with IV room 
automation.
• Lack of an ROI process may indicate direct cost savings is not a primary 
consideration and opportunity exists to better quantify savings associated 
with IV automation.
• Most respondents indicated projected medication error reduction pre-
implementation but few knew the projected or actual reduction post-
implementation
• Lack of staff changes indicate this technology may have aided in meeting 
higher volumes and expansion goals.
• A limitation to this survey was the low number of respondents.
Follow-Up on Pilot Survey (Future Research)
• Identify challenges to getting an IV automation project 
approved / funded
• Identify strategies that helped overcome challenges in 
implementation
• Identify observable measured outcomes to assess 
financial impact and patient safety impact of automated 
IV devices
•Develop best practice recommendations
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